Sell 12/31/2024Upgraded
NKGen Biotech, Inc. (NKGN) was upgraded to E+ from E on 12/31/2024 due to an increase in the volatility index and total return index.

Sell 11/4/2024Downgrade
NKGen Biotech, Inc. (NKGN) was downgraded to E from E+ on 11/4/2024 due to a major decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.2454 to -$0.6657, and operating cash flow declined 48.71% from -$4.03M to -$6M.

Sell 10/9/2023None
NKGen Biotech, Inc. (NKGN) was downgraded to E+ from U on 10/09/2023.